JPS5242840A - Novel pharmaceutically active compound - Google Patents

Novel pharmaceutically active compound

Info

Publication number
JPS5242840A
JPS5242840A JP51118924A JP11892476A JPS5242840A JP S5242840 A JPS5242840 A JP S5242840A JP 51118924 A JP51118924 A JP 51118924A JP 11892476 A JP11892476 A JP 11892476A JP S5242840 A JPS5242840 A JP S5242840A
Authority
JP
Japan
Prior art keywords
active compound
pharmaceutically active
novel pharmaceutically
novel
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51118924A
Other languages
English (en)
Japanese (ja)
Inventor
Ooke Subuenson Reifu
Magunusu Serenbiyuu Rarusu
Ingubuaa Reoborudo Buet Chieru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of JPS5242840A publication Critical patent/JPS5242840A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP51118924A 1975-10-01 1976-10-01 Novel pharmaceutically active compound Pending JPS5242840A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
JPS5242840A true JPS5242840A (en) 1977-04-04

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51118924A Pending JPS5242840A (en) 1975-10-01 1976-10-01 Novel pharmaceutically active compound

Country Status (19)

Country Link
JP (1) JPS5242840A (cs)
AT (1) AT347427B (cs)
AU (1) AU503212B2 (cs)
BE (1) BE846837A (cs)
CS (2) CS199643B2 (cs)
DD (1) DD126278A5 (cs)
DE (1) DE2640972A1 (cs)
DK (1) DK141622B (cs)
ES (1) ES451979A1 (cs)
FI (1) FI762660A7 (cs)
FR (1) FR2326183A1 (cs)
GB (1) GB1542317A (cs)
LU (1) LU75916A1 (cs)
NL (1) NL7610845A (cs)
NO (1) NO763345L (cs)
NZ (1) NZ182165A (cs)
SE (1) SE7510988L (cs)
SU (2) SU638252A3 (cs)
ZA (1) ZA765331B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163871D1 (en) 1980-07-09 1984-07-05 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
AU705320B2 (en) * 1995-12-28 1999-05-20 Welfide Corporation 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol or a pharmaceutically acceptable acid addition salt thereof for use in the preparation of a non-oral medicament, and for treatment of diseases and disorders
PL2332921T3 (pl) * 2003-06-17 2016-08-31 Arena Pharm Inc Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny
CA2646044A1 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
EP2099743B1 (en) 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
WO2009111004A1 (en) 2008-03-04 2009-09-11 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법
AU2011296014A1 (en) 2010-09-01 2013-04-04 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
EP2939677A1 (en) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration of lorcaserin to indviduals with renal impairment
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ｈｔ2ｃ 작동제의 변형-방출 투여 형태
CA2808904A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
MX2015004532A (es) 2012-10-09 2016-01-20 Arena Pharm Inc Metodo de control del peso.

Also Published As

Publication number Publication date
SU638252A3 (ru) 1978-12-15
SE7510988L (sv) 1977-04-02
ZA765331B (en) 1977-08-31
LU75916A1 (cs) 1978-05-16
NZ182165A (en) 1978-07-10
ES451979A1 (es) 1978-01-01
CS199644B2 (en) 1980-07-31
GB1542317A (en) 1979-03-14
ATA682376A (de) 1978-05-15
DE2640972A1 (de) 1977-04-14
AU503212B2 (en) 1979-08-30
DD126278A5 (cs) 1977-07-06
CS199643B2 (en) 1980-07-31
FI762660A7 (cs) 1977-04-02
FR2326183A1 (fr) 1977-04-29
AT347427B (de) 1978-12-27
NO763345L (cs) 1977-04-04
BE846837A (fr) 1977-04-01
SU674669A3 (ru) 1979-07-15
NL7610845A (nl) 1977-04-05
AU1812276A (en) 1978-04-06
DK141622B (da) 1980-05-12
DK439776A (cs) 1977-04-02

Similar Documents

Publication Publication Date Title
JPS51131843A (en) Lipidddepleted active compound
ZA776129B (en) Pharmaceutically active compounds
GB1539006A (en) Aminoalkylammonium compound
ZA763652B (en) Pharmacologically active compounds
ZA765498B (en) Pharmacologically active compounds
JPS57112389A (en) 1-sulfonylbenzimidazole compound
ZA767198B (en) Pharmacologically active compounds
ZA764082B (en) Pharmacologically active compounds
JPS51113900A (en) Riphamycin compound
JPS5228945A (en) Pharmaceutically active ooacyll 2*33diaryll33halogenn acrylaldoxim
JPS5242840A (en) Novel pharmaceutically active compound
ZA7682B (en) Pharmacologically active compounds
JPS5223076A (en) Antiiinflammatory compound
ZM9676A1 (en) Pharmacologically active compounds
JPS51143699A (en) Riphamycin compound
ZA761324B (en) Pharmaceutically active compounds
ZM9776A1 (en) Pharmacologically active compounds
JPS5236665A (en) 44dithioo33imide azethizinee 22one compound
PT65839B (en) Pharmacologically active compounds
ZA762536B (en) Pharmacologically active compounds
JPS5231062A (en) Perfluoroalkylthionorbornane compound
JPS5278869A (en) Thienylpolyene compound
GB1487036A (en) Pharmaceutically useful 2-aminoacetoamido-alpha-phenylbenzylideneaminoalkanol derivatives
JPS5271454A (en) Compound
JPS5227784A (en) Phenylsulfenylpiperazine compound